Drugs / Allogeneic Bone-Marrow Derived Mesenchymal Stromal Cells Secretome
Allogeneic Bone-Marrow Derived Mesenchymal Stromal Cells Secretome
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06919081 | Aug 2025 → Mar 2026 overdue | corneal disorder | University of Illinois at Chicago | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Bone-Marrow Derived Mesenchymal Stromal Cells Secretome | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06919081 ↗ |